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We report, for the first time, serologic evidence of
Rickettsia felis and R. aeschlimannii infections acquired in
Tunisia from 1998 to 2003. We found that most patients
with antibodies against both R. conorii and R. typhi had
serologic evidence of R. felis infection.
R
ickettsioses are arthropod-borne zoonoses with geo-
graphic distributions determined by the ecology of
their vectors. The genus Rickettsia is divided into 2 groups,
the spotted fever group (SFG) and the typhus group (TG),
mainly based on their intracellular positions, optimal
growth temperatures, gas chromatographic proportion (%),
DNAcontent, clinical features, epidemiologic aspects, and
antigenic characteristics. Recently, a new species of
Rickettsia that infected humans, R. felis, was reported (1),
and the whole genome of this species has recently been
sequenced (2). The pathogenic role of R. felis in humans
was demonstrated first in Texas (1), with subsequent
reports of this “fleaborne spotted fever” confirmed in
patients from Europe and South/Central America (3–5) by
polymerase chain reaction (PCR), serologic tests, or both.
In Tunisia, North Africa, the epidemiology of rickettsial
diseases has not been documented and only 1 study con-
cerning these diseases has been conducted. The study, con-
ducted in 1995, confirmed that R. conorii and TG rickettsia
were endemic in Tunisia, with estimated antibody preva-
lences of 9% and 3.6%, respectively (6). The aim of our
study was to investigate the diversity of rickettsioses in
Tunisia through the use of serologic assays.
The Study
Serum samples obtained from patients suspected to
have clinical rickettsial infection (fever associated with an
eschar or cutaneous rash) were collected from 1998 to
2003 at the Laboratory of Microbiology CHU Habib
Bourguiba, Sfax, Tunisia. Acute- and convalescent-phase
serum samples, when available, were stored at –80°C until
they were tested in a multiple-antigen immunofluores-
cence assay (IFA) at the Unité des Rickettsies Marseille
(7). Ten SFG rickettsial antigens were used: R.  conorii
conorii strain 7, R. africae strain ESF-5, R. sibirica mon-
golitimonae strain HA-91T, Rickettsia aeschlimannii strain
MC16T,  R. massiliae  strain Mtu1T, R. helvetica strain
C9P9, R. slovaca strain 13-B, R. conorii israelensis strain
ISTTCDC1, R. felis strain URRWXCal2 ATTC VR-1525,
and R. typhi strain Wilmington. Antigens were produced at
the Unité des Rickettsies Marseille as previously reported
(8). Immunoglobulin G (IgG) antibody titers of 1:128,
seroconversion in paired serum specimens, or IgM anti-
body titers of 1:32 against any species were considered
evidence of recent Rickettsia infection (7). 
Identification at the species level was determined by
Western blot (WB) and cross-adsorption assays in accor-
dance with procedures described elsewhere (7,8).  R.
conorii, R. aeschlimannii, R. felis, and R. typhi isolates
weresuspended briefly in sterile distilledwater and adjust-
ed to 2 mg protein/mL. Twenty microliters of theprepara-
tion was electrophoresed at 100 V for 2 h through a
separating gel containing 12% polyacrylamideby means of
a Mini-Protean II cell apparatus (Bio-Rad, Marnes la
Coquette, France). Amixture ofprestained molecular mass
standards (Kaleidoscope; Bio-Rad) was used to estimate
the molecular masses of the separated antigens. Resolved
antigens were transferred onto a 0.45-µm pore nitrocellu-
lose membrane (Bio-Rad) that was electrophoresed for 1 h
at 4°C and 100 V. The blots were blocked overnight at 4°C
with 5% nonfat milk powder in Tris-buffered saline (TBS)
and were washed with distilled water. Serum specimens
(diluted at a ratio of 1:200 in TBS with 3% nonfat milk
powder) were applied to the blots for 1 h at roomtemper-
ature. After three 10-min washes in TBS with 3% nonfat
milk powder, the blots were incubated for 1 h with perox-
idase-conjugated goat antihuman IgG (Southern
Biotechnology Associates, Birmingham, AL, USA) diluted
at a ratio of 1:750 in TBS with 3% nonfat milk powder.
The blots were washed 3 times in TBS, and bound conju-
gate was shown by incubation in a solution of 0.015%
4-chloro-1-naphthol (Sigma, Lyon, France) and 0.015%
hydrogen peroxide in TBS with 16.7% methanol for 15
min. WB analysis was done both before and after cross-
adsorption in accordance with procedures described else-
where (8). For patients with serologic evidence of R. felis
infection, epidemiologic and clinical data were collected
from medical records. 
From 1998 to 2003, 753 serum samples were collected
from 638 patients in Tunisia and sent to Marseille for
analysis. Paired serum specimens were available for 115
patients. Serologic evidence of recent Rickettsia infection
was found in 86 patients. Serum samples from 63 of these
patients exhibited wide cross-reactive antibodies between
SFG rickettsia and either R. felis (45 cases) or R. typhi (18
cases) (Figure); 19 serum samples had cross-reactive anti-
bodies between R. felis and R. typhi. Finally, 3 samples had
cross-reactive antibodies for SFG only (except R. felis),
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Sfax, Tunisiaand 1 serum sample was positive for R. typhi only. WB
with cross-adsorption analysis was performed for 21
serum samples, yielding species-level identification for 19
cases as follows: 3 R. conorii, 2 R. aeschlimannii, 6 R.
typhi, and 8 R. felis.
Clinical data were available for only 1 patient with R.
aeschlimannii infection. This patient had fever with
meningitis without inoculation eschar or cutaneous rash.
Serologic and clinical characteristics were available for 8
patients with R. felis infection (Table); most of the patients
lived in urban areas, and 1 came from Libya. All 8 patients
had fever and a maculopapular rash, and none reported a
history of flea or tick bite or had an eschar. Two patients
had peripheral adenopathy on admission: cervical and
inguinal in the first patient and axillary and inguinal in the
second patient.
Conclusions
In this study, IFAand WB identified R. felis infection in
patients from Tunisia. Serologic cross-reactions are com-
mon among Rickettsia species in both the SFG and TG. A
difference in specific IgG or IgM antibody titers has been
useful for distinguishing murine typhus from epidemic
typhus (8). More sophisticated serologic methods are
needed to identify the causative agent at the species level
(9). WB performed on 7 of 18 serum samples with cross-
reactions between SFG, R. felis, and R. typhi confirmed the
diagnosis of R. felis in 5 patients and TG rickettsia in 1
patient; the diagnosis remained undetermined in 1 patient.
Recently, the whole genome of R. felis has been sequenced
and demonstrated genetic similarity with R. typhi but
showed some genes missing from the R. conorii genome
(2). Thus, R. felis may be the major cause of cross-
reactions between R. typhi and R. conorii or other tick-
borne spotted fever agents. Cross-reactions between the 2
groups of Rickettsia have been puzzling because this activ-
ity is not reported in experimentally infected guinea pigs
and mice (10). In fact, we speculate that many of the reac-
tions with both R. typhi and R. conorii are caused by R.
felis infection. This hypothesis is supported by our find-
ings of cross-reactivity in serum specimens from 5 of 7
patients with confirmed R. felis infection. Indeed, when
antigens are not available, this cross-reactivity should be a
good screening method for R. felis infection. Alternatively,
all serum specimens exhibiting cross-reactivity between R.
typhi and R. felis only were considered to be TG rickettsia
infection after WB.
To the best of our knowledge, this is the first report of
patients with R. felis and R. aeschlimannii infections in
Tunisia. In Morocco, similar results have been reported
(11). Several cases of SFG rickettsioses have been report-
ed from North Africa, including 1 patient with R. aeschli-
mannii infection from Morocco (12) and 1 patient with R.
sibirica mongolitimonae infection from Algeria (13).
These results are not surprising since vectors of R. felis and
R. aeschlimannii are present in North Africa (14). Indeed,
R. aeschlimannii has been isolated from Hyalomma mar-
ginatus ticks collected from camels in Morocco (15), and
R. felis–infected fleas in Algeria have been recently report-
ed (14). Since R. felis has a worldwide distribution and
infestation with these fleas is very common, R. felis and
fleaborne spotted fever may occur worldwide. 
Only a few human cases of R. felis infection diagnosed
by serologic tests or PCR have been reported: 1 case from
the United States (Texas) (1), 3 from Mexico (3), 2 from
France, 2 from Brazil (4), and 2 from Germany (5). In the
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Figure. Pictures of immunofluorescence
assay performed on serum specimens
with proven Rickettsia conorii (A), R. felis
(B), or R. typhi  (C) infection showing
cross-reactive antibodies. Antigens tested
were R. conorii (column 1), R. felis (col-
umn 2), and R. typhi  (column 3). The
serum with R. conorii infection reacts with
R. conorii and  R. felis antigens but not
with R. typhi (A). Conversely, the serum
with R. typhi infection reacts with R. typhi
and R. felis but not with R. conorii (C).
Finally, the serum with R. felis infection
reacts with R. felis, R. conorii, and R.Texas case (1), the patient had clinical features similar to
those associated with murine typhus. However, patients
with R. felis and central nervous system and pulmonary
involvement have been reported from Mexico (3). In our
study, 1 of the patients with R. felis infection had pul-
monary involvement and 2 had adenopathy. Although none
had an eschar or a history of flea bite, 3 patients had con-
tact with animals. 
Our findings indicate the need for further studies to
determine the distribution of R. felis and the prevalence of
this agent and associated infection. These results suggest
that fleaborne spotted fever, as well as other SFG rick-
ettsioses, are common in Tunisia.
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